Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05635201Phase 3Completed
A Phase 3 trial of remimazolam in general anesthesia, sponsored by Daegu Catholic University Medical Center. Started Dec 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05635201.